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Background: Manual cervical distraction (MCD) is a traction-based therapy performed with a manual contact over
the cervical region producing repeating cycles while patients lie prone. This study evaluated a traction force-based
minimal intervention for use as an attention-touch control in clinical trials of MCD for patients with chronic neck
pain.
Methods: We conducted a mixed-methods, pilot randomized clinical trial in adults with chronic neck pain. Participants
were allocated to three traction force ranges of MCD: low force/minimal intervention (0-20 N), medium force (21-50 N),
or high force (51-100 N). Clinicians delivered five treatments over two weeks consisting of three sets of five cycles of
MCD at the C5 vertebra and occiput. Traction forces were measured at each treatment. Patient-reported outcomes
included a pain visual analogue scale (VAS), Neck Disability Index (NDI), Credibility and Expectancy Questionnaire
(CEQ), and adverse effects. A qualitative interview evaluated treatment group allocation perceptions.
Results: We randomized 48 participants, allocating an average of five each month. Forty-five participants completed
the trial with three participants lost to follow-up. Most participants were women (65 %) and white (92 %) with a mean
(SD) age of 46.8 (12.5) years. Mean traction force values were within the prescribed force ranges for each group at the
C5 and occiput levels. Neck pain VAS demonstrated a benefit for high traction force MCD compared to the low force
group [adjusted mean difference 15.6; 95 % confidence interval (CI) 1.6 to 29.7]. Participants in the medium traction
force group demonstrated improvements in NDI compared to the low force group (adjusted mean difference 3.0; 95 %
CI 0.1 to 5.9), as did participants in the high traction force group (adjusted mean difference 2.7; 95 % CI -0.1 to 5.6). CEQ
favored the high force group. Most low force participants correctly identified their treatment allocation in the qualitative
interview. No serious adverse events were documented.
Conclusions: This pilot study demonstrated the feasibility of a clinical trial protocol and the utility of a traction-based,
minimal intervention as an attention-touch control for future efficacy trials of MCD for patients with neck pain.
Trial registration: ClinicalTrials.gov NCT01765751 (Registration Date 30 May 2012)
Keywords: Adverse effects, Chiropractic, Clinical trial, Control groups, Forces, Traction, Manual therapy, Musculoskeletal
manipulations, Neck pain, Outcome assessments, Traction* Correspondence: gudavalli_r@palmer.edu
1Palmer Center for Chiropractic Research, Palmer College of Chiropractic, 741
Brady Street, 52803 Davenport, IA, USA
Full list of author information is available at the end of the article
© 2015 Gudavalli et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution
License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Gudavalli et al. Trials  (2015) 16:259 Page 2 of 16Background
Chronic neck pain is a common musculoskeletal complaint
associated with radiating symptoms to the head, upper ex-
tremities or thoracic regions, muscle stiffness, sensori-
motor dysfunction, headache, vertigo, and psychological
complaints [1–4]. The 12-month prevalence of neck pain
in adults is estimated at 30 % to 50 % [5], with symptoms
reported more frequently by women and middle-aged
people [6–8]. Health service utilization among patients
with neck pain is substantial, with 10.2 million visits to US
healthcare facilities registered in 2007 [9].
Pharmacological and surgical interventions for chronic
neck pain are available [9, 10], but many procedures are
costly, leading to rising healthcare expenditures for this con-
dition [11, 12]. In addition, non-steroidal anti-inflammatory
medicines, opioids, spinal injections, and spine surgery have
high-risk side effects [13–15] and may deliver only mar-
ginal improvements to patients’ clinical outcomes, work-
related productivity and quality of life measures [11, 12].
Preliminary evidence suggests that manual therapies may
provide similar benefits to patients with chronic neck pain
as conventional medical treatments, with better tolerance
and safety profiles [16–19]. However, a recent systematic
review recommends additional studies to determine the
efficacy of specific manual therapies to clinical outcomes
in this patient population [20].
Clinical studies involving mechanical or manual ther-
apies have demonstrated mixed clinical outcomes in pa-
tients with chronic neck pain [21–25]. These conflicting
results are likely due to varying study methodologies
and quality levels, preventing a conclusive determin-
ation of the efficacy of mechanical traction and other
manual therapies for the relief of neck pain [26–31]. To
improve the quality of such studies, recent systematic
reviews have encouraged researchers to develop sham
or minimal interventions to serve as control groups for
clinical trials of manual treatments for neck pain [17,
32]. Toward this aim, our team conducted a series of
basic science and clinical studies to develop a minimal
intervention to serve as an attention-touch control
group for efficacy trials of manual cervical distraction
(MCD).
MCD is an intermittent traction procedure that differs
from mechanically based traction therapies. MCD is de-
livered using a manual contact over different vertebral
levels of the cervical spine in slow, repeating phases
while the patient lies prone, whereas mechanical traction
uses a head harness attached to weights or computer
controlled tensioning equipment with patients in supine
or upright positions [33]. MCD is hypothesized to create
intersegmental separation at targeted vertebral levels,
which contributes to generating a therapeutic effect [34].
Although MCD is used in the care of persons with neck
pain [35–39], no published clinical trials have evaluatedthe efficacy of this therapy, in part due to the lack of ad-
equate sham treatments or control intervention.
Our investigative team conducted a series of preliminary
studies to develop a sham treatment or minimal interven-
tion to serve as an attention-touch control for randomized
controlled trials of MCD. Our objective in these studies
was to identify cervical traction force ranges that demon-
strated no intradiscal pressure decreases, but that patients
with neck pain believed to be a credible treatment. In the
first preliminary study, Gudavalli and colleagues (2013)
confirmed that MCD decreased cervical spine intradiscal
pressures in cadaveric specimens, even with traction
forces as light as 20 N [40]. We then evaluated the per-
ceived sensations of participants undergoing MCD to
identify force ranges that participants classified as non-
therapeutic, possibly therapeutic, and definitely thera-
peutic, with patients confirming 25.5 N as a possibly
therapeutic level of traction force [41]. Based on the re-
sults of these preliminary studies, we concluded that de-
veloping a low-force minimal intervention will be a better
choice than a sham treatment. We next developed a force
feedback technology [42] to allow clinicians to deliver
MCD within distinct traction force ranges, and tested a
training and certification process using this technology
[43]. These data led us to conclude that MCD could be
delivered consistently within three different traction force
ranges [44]. Our team then assessed clinician proficiency
in delivering specified traction forces during a pilot ran-
domized clinical trial (RCT) of MCD [45, 46].
The primary objective of this investigation was to
evaluate a traction force-based, minimal intervention for
patients with neck pain to use as an attention-touch
control in future fully powered randomized trials study-
ing MCD. This article also reports additional findings
from this pilot RCT, including the feasibility of our par-
ticipant recruitment plan and treatment protocol, the re-
sults of patient-reported outcomes (PROs), traction
forces delivered, and patient perceptions of the three
force-based treatment groups. Our presentation follows
recent commentaries on reporting results of clinical trial
pilot studies [44, 47].
Methods/design
This pilot RCT with a nested qualitative study compared
three traction force ranges of MCD in 48 adults with
chronic neck pain. Participants were randomized to one
of three study groups: 1) low force/minimal intervention
[0-20 Newtons (N)], 2) medium force (21 N-50 N), or 3)
high force (51 N-100 N) MCD. At each treatment visit,
participants received three sets of five repetitions of trac-
tion with a neutral head position, delivered within the al-
located force range and at two contact points (C5 and
occiput). Participants completed five study visits over
two weeks, with PROs collected at baseline visit 1 (BL1)
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study visits. Primary PROs included the Visual Analogue
Scale (VAS) for neck pain and the Neck Disability Index
(NDI). Secondary PROs included the Patient Reported
Outcomes Measurement Information System (PROMIS-
43) general health status scale and patient satisfaction.
Patient perceptions of study treatments and adverse
events also were assessed. We evaluated participant
blinding to their study intervention in a qualitative inter-
view conducted after receiving their fifth MCD treat-
ment on the last study visit.
Ethical considerations
The Palmer College of Chiropractic Institutional Review
Board approved the study protocol and human subjects
protection procedures for this trial (Approval #2012G151,
date 1 November 2013). Study coordinators provided an
overview of the research procedures and played a video-
recording that demonstrated the study procedures. The
RCT was not identified as a pilot study in the consent; how-
ever, the written document identified all required elements
for informed consent [48]. All participants read and signed
the written consent document before the BL1 evaluation.
Participant eligibility and recruitment
We recruited participants of both genders, 18- to 70-years
old using strategies that were successful in previous stud-
ies, including direct mail postcards, media releases, and
internet postings [49]. Our targeted sample size was 45
participants. Participants completed a multi-stage eligibility
determination process that included a telephone screen; in
person informed consent process, questionnaires, clinical
interview and examination by a Doctor of Chiropractic
(DC); and a panel-based case review [50]. Eligible partici-
pants had self-reported neck pain or neck-related upper
extremity pain of at least four weeks duration ranging in
intensity from 3 to 7 on an 11-point (0 to 10) numerical
rating scale (NRS) on the telephone screen [51]. Partici-
pants were not excluded for previous treatment of this
episode of neck pain. However, because our primary aim
was to develop a minimal intervention for MCD, partici-
pants could not have had any previous experience receiv-
ing flexion-distraction technique to the cervical spine.
Table 1 displays each eligibility criterion with the corre-
sponding rationale. Participant progress through the trial
was recorded via a secure, password-protected, web-
based tracking system according to CONSORT 2010
standards [52].
Setting
This study was conducted at the Palmer College of
Chiropractic, Palmer Center for Chiropractic Research,
in Davenport, IA, USA. The dedicated research clinic is a
250 square meter (2,700 square foot) facility withconsultation, exam, and treatment rooms, clinical bio-
mechanics laboratory and radiology suite. The clinic is
staffed with research clinicians who are licensed DCs,
study coordinators, and a research participant coordin-
ator. The laboratory is staffed by biomechanics faculty and
research assistants. Participants completed data collection
and interviews in a private consultation room. Treatments
and biomechanical measurements took place in a single
room equipped with the treatment table and computer-
ized biomechanical instrumentation, and staffed with up
to three research personnel.
Study visits
Volunteers were screened by telephone and, if eligible,
scheduled for a baseline visit (BL1) that included the in-
formed consent process, baseline measures, an interview
by a study coordinator, medication and health history re-
view, an eligibility exam by a DC and, if indicated, a cer-
vical radiographic evaluation. BL1 eligible participants
were presented by the examining clinician to the case re-
view panel, which rendered an eligibility determination
[50]. The case review panel consisted of a co-investigator,
project manager, clinicians, and study coordinators. Eli-
gible participants at a second baseline visit (BL2) were
assigned at random to one of three intervention groups
and completed study visit 1 (SV1). Participants completed
five study visits scheduled at least one day apart over two
weeks with no more than three study visits during any sin-
gle week. Study visits included questionnaires, clinical as-
sessments, group-specific interventions, and specified
research measurements.
Treatment group allocation
Participants were allocated to one of three treatment
groups with a predetermined blocked randomization
scheme with random block sizes of three or six created
with computerized random numbers in a 1:1:1 ratio. A
research clinician entered the participant identification
number into the study-specific, web application that
generated the coded treatment group, which was known
only to the clinician. This web application algorithm
concealed future group assignments.
Intervention
MCD is a form of low velocity variable amplitude spinal
manipulation [34]. Figure 1 depicts the instrumented Cox
Flexion-Distraction Table (Version 7, Haven Innovations
Inc., Detroit, MI, USA) used for all trial treatments. The
table includes a moveable headpiece that allows for guided
head movement in multiple directions; however, only
cephalic movement (traction) with the head in a neutral
position was used in this study. During MCD, the partici-
pant laid prone on the treatment table while the clinician
gently grasped the posterior aspect of the participant’s
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thumb and index finger at a specific vertebral level (stan-
dardized at C5 and occiput). With the opposite hand, the
clinician held a control handle attached to the headpiece.
Using the contact hand, the clinician exhibited superior
traction while ensuring gentle headpiece movement via
the control handle. The weight of the participant’s headTable 1 Eligibility criteria
Inclusion criteria Ration
Neck or neck-related upper limb pain consistent with Quebec Task
Force (QTF) classifications 2-4 [75]
Study
extrem




Neck pain without radiation (QTF classification 1) [75] Interve
Presumptive compression of a nerve root on roentgenogram
(i.e, instability fracture) (QTF classification 5)
May re




Spinal stenosis (QTF classification 7) May re
may li
Postsurgical status <6 months (QTF classification 8) May re
interpr
Postsurgical status >6 months (QTF classification 9) May re
interpr
Chronic pain syndrome (QTF classification 10) Care n
Other diagnoses from visceral disease, metastasis, etc. (QTF
classification 11)
Care n
Inflammatory arthritis in the cervical spine: i.e., rheumatoid arthritis,
systemic lupus erythematosus
Study
Neurological (spinal) instability in cervico-thoracic spine Treatm
Tumors, within or adjacent to the cervico-thoracic spinal canal Treatm
Arnold Chiari malformation May re
Spinal joint hypermobility, such as: Marfan syndrome,
Ehlers-Danlos syndrome, osteogenesis imperfecta
May in
Advancing neurologic deficits Treatm
Sequestered intervertebral disc or loose body within the cervical
spinal canal, lateral recess, or intervertebral foramen
Safety
Fusion (single or multisegmental) of the cervical vertebrae Joint d
princip
Safety precaution (e.g., unable to ambulate within clinic, dizziness,
weight beyond treatment table limits [300 lbs])
Safety
Unable to tolerate study procedures Safety
Simultaneous management for a condition compromising ability to
deliver study treatment or assess health status
Safety
Suspicion of alcohol or drug abuse May in
require
Cognitive or memory impairment May p
reduce




studyand the light pressure from the manual contact was suffi-
cient to maintain contact with the headpiece during the
traction movement. The procedure produced a rhythmic,
localized distractive movement lasting one to three sec-
onds per repetition. Based on the findings of a preliminary
study of patient perceptions of MCD traction forces [41],
we limited cervical traction forces to less than or equal toale
intervention was designed to treat radiating neck pain (proximal or distal
ity) with or without neurological signs
ent credibility assessment requires unfamiliarity with study interventions
ale
ntion designed to treat radiating neck pain
quire individualized treatment not available in trial
quire individualized treatment not available in trial; condition may limit
etation of study measurements
quire individualized treatment not available in trial; condition
mit interpretation of study measurements
quire individualized treatment not available in trial; condition may limit
etation of study measurements
quire individualized treatment not available in trial; condition may limit
etation of study measurements
eeded is outside study scope
eeded is outside study scope
treatments are not intended for these conditions
ent needed is outside study scope
ent needed is outside study scope
quire referral, additional evaluation or treatment outside study scope
terfere with data collection and interpretation
ent needed is outside study scope
precaution




precaution and may present an undue scheduling burden
terfere with data collection, ability to comply with study protocol, and
s referral
rohibit informed consent or compromise safety due to potentially
d comprehension or compliance with study procedures
precaution and advanced diagnostic testing outside study scope
ortation issues, scheduling conflicts, etc. may compromise adherence to
protocol
Fig. 1 Head and thorax support sections of instrumented manual
distraction treatment table used in the study
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medium force group, and between 51 N and 100 N in the
high force group. Dosing was limited to three sets of five
repetitions with contact over the C5 cervical vertebra and
three sets of five repetitions with contact on the occiput.
To insure inter- and intra-clinician proficiency in treatment
implementation [46], we conducted pre-trial training ses-
sions and monthly clinician recertification on traction
force delivery using a process described elsewhere [43].
Participants wore a collarless shirt and placed their
hands under their thighs instead of on the table hand
rests, if able, to assure consistent positioning and force
measures between participants and study visits (Fig. 2).
All moveable sections of the table were locked in place
except for the axial (cephalic) movement mechanism of
the headpiece. We used only traction with a neutral
head position (Cox protocol 1) [34] to standardize treat-
ment delivery between participants and study visits.
Measurements
Additional measures were as follows. A verbal 0 to 10
numerical rating scale for pain was used at the telephone
screen for eligibility determination due to its ease ofFig. 2 Photographs showing (a) participant lying prone on treatment tableadministration for data collection [51]. We collected
demographics at the phone screen and at the BL1. We
assessed participants at BL1 for severe depression using
the Beck Depression Inventory [53]. Study coordinators
completed a medication checklist with participants at SV1
and SV5. PROs and questionnaires to assess treatment
credibility and participant expectations were collected on
participant-administered paper forms at BL1 and before
treatment delivery at SV1 and SV5. Cervical traction
forces were collected during each treatment. Cervical
range of motion was measured at SV1 and SV5. A qualita-
tive interview was completed after other study procedures
on SV5. There were no follow-up assessments.
Patient-reported outcomes
PROs included the Visual Analogue Scale (VAS), Neck
Disability Index (NDI), the Patient Reported Outcomes
Measurement Information System (PROMIS-43) general
health status scale, and patient satisfaction. The VAS is a
single-item, unidimensional measure for pain with excel-
lent metric properties, easy administration and scoring
that is commonly used in pain-related research [51]. Our
anchors for current neck pain were ‘no pain’ to ‘worst im-
aginable pain’ using a 0 to 100 mm scale, which allowed
for more sensitive assessment of pain intensity compared
to the NRS due to its increased number of response levels
[54]. Score interpretations for the VAS include the follow-
ing cut points: no pain (0 to 4 mm), mild pain (5 to
44 mm), moderate pain (45 to 74 mm), and severe pain
(75 to 100 mm) [55]. The NDI is a 10-item questionnaire
modified from the Oswestry Disability Index for low back
pain [56, 57]. The NDI is a reliable and valid measure of
disability due to neck pain, and responsive for measuring
change on a scale of 0 to 50. Following the Initiative on
Methods, Measurement and Pain Assessment in Clinical
Trials (IMMPACT) recommendations for chronic pain
clinical trials, we measured several additional core out-
comes, including physical and emotional function [58]
using the PROMIS-43 to evaluate pain interference,and (b) clinician hand contact at C5 vertebral level
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ticipants rated their satisfaction with various elements of
the study (e.g., treatments received, clinicians) using a 5
category response from 1 (strongly satisfied) to 5 (strongly
dissatisfied) with categories collapsed into satisfied (cat-
egories 1 and 2) or not satisfied (categories 3, 4 or 5) for
interpretation.Cervical traction forces
A research assistant trained in biomechanical measure-
ments recorded cervical traction forces during all study
visits. The treatment table was modified to include force
plates and motion sensors (Model 4060-1000, Bertec
Inc., Columbus, OH, USA) to measure traction forces
and table movement. Force plates were connected to a
computer through an analog-to-digital converter. Mo-
tion Monitor Software (Version 7.1, Innovative Sports
Training Inc., Chicago, IL, USA) collected data from the
force plates and motion sensors at a sampling rate of
100 Hz. Data were exported to text file using the export
function of the software. Custom written Matlab software
(Version 7, Mathworks Inc., Natick, MA, USA) read the
exported data and graphed the forces as a function of the
duration of treatment. A research assistant then used start-
ing and end time points on the force-time graph to extract
the peak traction forces between these time points. Peak
forces data were exported from Matlab to an MS-Excel
2010 file (Microsoft Corporation, Redmond, WA, USA)
and the average peak force in N was computed.Credibility and Expectancy Questionnaire
Participants’ perceptions of the study treatments were
compared across groups using the Credibility and Expect-
ancy Questionnaire (CEQ) [60, 61]. The CEQ credibility
factor relates to how logical or believable a treatment is
for the patient, whereas the expectancy factor refers to the
patient’s beliefs about improvements that might be
achieved from the treatment [61]. CEQ scores for both
the credibility and expectancy factors range from 3 to 27,
with higher scores indicating greater belief in treatment
credibility or expectancy for clinical improvement. Psy-
chometric evaluations of the CEQ in varying populations
demonstrated high internal consistency (standardized α =
0.79 to 0.90 expectancy; Cronbach’s α = 0.81 to 0.86 cred-
ibility; standardized α = 0.84 to 0.85 whole scale), good
inter-item correlations (expectancy ranging from 0.53 to
0.85; credibility ranging from 0.62 to 0.78) and high test-
retest reliability over one-week (0.82 expectancy; 0.75
credibility) [61]. Participants completed the CEQ at the
BL1 after reading the consent document and viewing the
introductory video about MCD, at the SV1 after receiving
the MCD treatment for the first time, and at the SV5 be-
fore receiving their final treatment.Qualitative interviews
As this was a pilot study evaluating a novel minimal inter-
vention for use as an attention-touch control in future
clinical trials, we assessed participants’ perceptions of
study treatments through standardized qualitative inter-
views, as recommended in a previous placebo-controlled
trial of manual therapies [62]. One investigator (SAS) who
has expertise in qualitative methods conducted all inter-
views with participants after their completion of the PROs,
biomechanical measures, and MCD treatment at SV5. A
professional transcriptionist transcribed the interviews
verbatim. The interviewer was blinded to treatment group
until after a question on treatment group assignment was
asked during the interview schedule. Qualitative data were
imported into NVIVO software (Version 9, QSR Inter-
national Pty Ltd., Doncaster, Victoria, Australia) to facili-
tate data management and qualitative content analysis
[63]. We appraised whether participants correctly identi-
fied their treatment group assignment (low force, medium
force or high force) and their reasons for attributing treat-
ment allocation to this group. Responses were broken
down into discrete statements, marked with codes, and
grouped into themes based on recurring patterns [64].
Data management
We have described our data management procedures else-
where [65, 66]. All data collection forms had unique par-
ticipant identification numbers. Data forms were stored in
locked filing cabinets or on a secure, password-protected
server accessible only by study personnel. Data were
double-key entered into computer databases that contain
range and logic checks for accuracy. Electronic data were
stored on an internal Microsoft SQL Server secured with
Secure Socket Layers (SSL). Biomechanical data were
stored on a secured network drive. Analytic and qualita-
tive files were maintained on a secure, password-protected
server.
Sample size
This pilot RCT was not a powered study. We targeted a
sample size of 15 per group (n = 45) to provide adequate
participant contact to evaluate study protocol feasibility
and recruitment strategies and to assess the believability
characteristics of the three traction force-based treat-
ments. We also estimated group differences in mean
changes and standard deviations in the outcome mea-
sures. These aspects of the study protocol were selected
as key to informing the design of a full‐scale efficacy trial
of MCD.
Statistical methods
Participants who had non-missing data for the primary
outcomes were analyzed according to their original
treatment assignment. We performed quantitative data
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Inc., Cary, NC, USA). Change in PROs from BL1 to SV5
(before biomechanical measurements and treatment)
were compared between groups with analysis of covari-
ance (ANCOVA), adjusting for the BL1 value of the re-
spective variable centered at its mean. We then entered
baseline variables that were imbalanced among groups,
as well as a variable differentiating if the intervention
was aided by visual feedback, into the models one at a
time. Only variables significant at the 0.10 level were
kept in the final models. Adjusted within group changes
and between group differences in mean change and
95 % confidence intervals based on the final ANCOVA
models are presented.
Blinding protocol
Clinicians were not masked to group assignment, but
were blinded to PROs. Study coordinators, examining
clinicians, investigators and analysts were blinded to
group assignment. Biomechanical technicians were
blinded to group assignment but not traction forces,
while research assistants completing data reduction were
blinded to group assignment. The qualitative interviewer
was blinded to group assignment during the exit inter-
view until the participants were asked a specific question
on treatment group assignment, at which point the par-
ticipant and researcher were unmasked to treatment
group. However, the qualitative researcher was masked
to treatment group during data coding. Participants were
masked to group assignment during the trial until ques-
tions on the exit interview specifically asked them to
guess their treatment group assignment.
Safety, protocol deviation and compliance monitoring
Recent articles have called for more consistent, in-depth
and standardized monitoring of adverse events related to
manual therapies [67–71]. Toward that aim, we carefully
monitored adverse events (AE) and serious adverse events
(SAE) using an active surveillance process described else-
where [65, 66]. AEs were defined as any untoward medical
occurrence that may present itself during the conduct of
the study which may or may not have a causal relationship
with the study procedures [72]. SAEs were defined as any
adverse experience occurring during treatment that results
in any of the following outcomes: death, life-threatening
adverse experience, hospitalization, persistent or signifi-
cant disability or incapacity, or a congenital anomaly or
birth defect [72]. Clinicians collected AE data by directly
querying participants about any new injuries, side effects
or symptoms at each visit. Positive responses initiated the
completion of an Adverse Event Report, with all reported
AEs and SAEs graded on three criteria: 1) severity; 2) ex-
pectedness; and 3) relatedness to the study interventions.
The informed consent document disclosed muscle sorenessor stiffness, light-headedness or dizziness, headache and
exacerbation of neck pain symptoms as AEs experi-
enced by patients receiving manual therapy for neck
pain [73, 74].
Protocol deviations were tracked using a study-specific,
web application that included the date of occurrence, par-
ticipant(s) involved, detailed event notes, and investigator
response. Participant compliance was tracked through the
scheduling database that included details on missed ap-
pointments and study dropouts.
Results
Participant flow and recruitment feasibility
Figure 3 presents the participant flowchart. We com-
pleted 291 telephone screens, with 210 participants eli-
gible for the BL1 clinic screen. Ninety-six participants
were presented at case review, with 60 participants eli-
gible for the BL2 clinic screen. In total, 109 participants
chose not to participate in the trial and 134 participants
were excluded. The most common reasons participants
did not enroll in the study were non-attendance at a
scheduled appointment (n = 43), time or other outside
commitments (n = 30), not interested (n = 16), not willing
to stop treatment from another provider (n = 5), other
health concern (n = 4), neck condition not requiring treat-
ment at this time (n = 3), not willing to receive study treat-
ments (n = 2), or non-specified reasons (n = 6). The most
common exclusions were for a neck pain rating of ≤2 on
the NRS (n = 37), a neck pain rating of ≥8 on the NRS
(n = 32), current litigation (n = 10), inability to tolerate
study procedures during BL1 screening (n = 9), the need
for referral or concurrent treatment identified during BL1
screening (n = 6), Quebec Task Force classification of neck
symptoms outside the ratings of 2, 3, or 4 (n = 6), multiple
exclusions (n = 17), or other exclusions (17). We random-
ized 48 participants to treatment, allocating an average of
five participants each month (range 1 to 10 participants/
month). Forty-five participants completed the trial and
three participants were lost to follow-up (two medium
force participants and one high force participant). We
were unable to ascertain the reasons these three partici-
pants dropped out of the study. Only four participants
missed any of the five scheduled treatment visits; of these,
three participants were those who later withdrew from the
study, missing two, three, and four treatments, respect-
ively. We opted not to perform study treatments or bio-
mechanical tests on one participant who experienced an
adverse event (described below) following the first study
visit. This participant did not attend two study visits, but
completed all outcome measures.
Baseline demographic and clinical characteristics
Table 2 depicts the BL1 characteristics of participants by
treatment group. Overall, most participants were women
Fig. 3 Participant flow diagram
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(12.5) years. All participants were classified with neck
pain consistent with category 2 (radiation to the prox-
imal extremities) or 3 (radiation to distal extremities) of
the Quebec Task Force for Spinal Disorders [75]. These
categories are roughly equivalent to severity grades 1
and 2 proposed by the Neck Pain Task Force for patients
with neck pain who seek healthcare [76]. Most partici-
pants (90 %) had received chiropractic care in the past,
although only 25 % of the sample considered themselves
as someone who regularly receives chiropractic care.Current neck pain on the VAS at BL1 for the sample
was a mean (SD) of 41.3 (15.4) indicating mild neck pain
[55]. Participants allocated to the higher force group re-
ported lower levels of current pain at BL1 than participants
in the other groups. The NDI scores for the sample mea-
sured a mean (SD) of 11.0 (4.1), consistent with a mild dis-
ability from neck symptoms [77]. Participants reported a
mean duration of neck pain of 14 years, ranging from 1-45
years. Participants’ self-reported cause of neck pain in-
cluded a gradual onset (n = 17), no known cause (n = 8), of-
fice or desk work (n = 7), motor vehicle accidents (n = 6),
Table 2 Participant characteristics at baseline
Characteristic Low Force Medium Force High Force
(n = 16) (n = 16) (n = 16)
Age in years, mean (SD) 42.2 11.2 47.0 11.4 51.2 13.7
Female, n (%) 11 69 12 75 8 50
White, n (%) 15 94 14 88 15 94
Married, n (%) 7 44 10 63 9 56
Education, high school graduate or higher, n (%) 16 100 16 100 15 94
Employment, full-time, n (%) 11 69 9 56 8 50
Previous chiropractic, n (%) 16 100 14 88 13 81
Regular chiropractic care, n (%) 3 19 5 31 4 25
Body mass index, mean (SD) 31.3 6.9 30.3 6.3 26.9 5.3
Beck depression index, mean (SD) 5 3.8 5 5.0 4 3.7
Current neck pain, Visual Analog Scale (0-100 mm), mean (SD) 45.2 18.0 44.3 14.1 34.5 12.3
Neck disability index (0-50), mean (SD) 10.8 4.0 11.1 4.5 11.1 3.9
Neck pain or symptom radiation pattern (may indicate more than 1 location of symptom radiation)
Head, n (%) 1 6 2 13 2 13
Thoracic, n (%) 3 19 2 13 4 25
Shoulder, n (%) 8 50 3 19 8 50
Upper arm, n (%) 1 6 0 0 2 13
Distal arm/hand, n (%) 3 19 8 50 2 13
Quebec Task Force Classification
QTF 2, n (%) 11 23 11 23 14 29
QTF 3, n (%) 5 10 5 10 2 4
PROMIS-pain interference, mean (SD) 53.2 6.7 54.9 5.2 51.2 5.6
PROMIS-physical function score, mean (SD) 27.7 5.2 25.3 5.0 26.4 4.5
PROMIS-sleep disturbance, mean (SD) 51.3 3.0 51.3 3.0 51.5 2.6
PROMIS-fatigue, mean (SD) 50.4 10.9 46.4 9.3 47.1 7.2
PROMIS Patient-Reported Outcomes Measurement Information System, QTF 2 Quebec Task Force Rating 2 - pain and radiation to proximal extremity, QTF 3
Quebec Task Force Rating 3 - pain and radiation to distal extremity
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tal fall (n = 2). Participants reported a mean of 2.5 (range
0 to 7) neck pain aggravators, with frequent aggravators
noted as seated posture (n = 18), reading (n = 15), com-
puter use (n = 13), sleep position or quality (n = 9), driving
(n = 8), neck or head motions (n = 8), lifting (n = 8), stress
(n = 8), motor vehicle accidents (n = 6), sports participation
or injuries (n = 6), housework (n = 5), office or desk work
(n = 4), standing posture (n = 2), weather change (n = 2),
music playing (n = 2), and other aggravators (n = 8).
Patient-reported outcomes
Pain intensity at baseline was significant (p = 0.07) in the
model for change in pain interference and, therefore,
remained in the final reported model. The traction-force
feedback method was significant in the models for
change in VAS (p = 0.06) and change in NDI (p = 0.01),
and remained in the final reported models. Sex and BMI
were not significant in any of the models.Neck pain intensity
The raw mean VAS at baseline and SV5 for each group is
given in Fig. 4. Adjusted mean neck pain VAS change
(95 % confidence interval) was 9.1 mm (-1.6 to 19.8 mm),
18.9 mm (7.7 to 30.1 mm), and 24.7 mm (13.9 to
35.5 mm) for the low, medium and high force groups, re-
spectively. The adjusted mean neck pain intensity change
for the high traction force MCD group was significantly
greater (15.6 mm) than the low force group (Table 3). The
adjusted mean neck pain intensity change was 9.8 mm
greater for those in the medium traction force MCD than
those in the low force group, but there was little difference
compared to the high force group (5.8 mm).Neck-related disability
The raw mean NDI at baseline and SV5 for each group
is given in Fig. 5. Adjusted mean NDI change (95 % con-
fidence interval) was 1.3 (-1.0 to 3.5), 4.2 (1.8 to 6.6),
Table 3 Adjusted mean differences of patient-reported outcomes
Outcome variable Treatment group comparison
Neck Pain VAS (mm)b High vs. Low
Medium vs. Low
High vs. Medium








Physical Function High vs. Low
Medium vs. Low
High vs. Medium




Sleep Disturbance High vs. Low
Medium vs. Low
High vs. Medium
High High force group (51 to 100 Newtons), Low Low force group (0 to 20 Newtons
Outcomes Measurement Information System, VAS Visual Analog Scale
aAdjusted for the baseline value of the respective variable centered at its mean;
bAlso adjusted for traction-force feedback method; cAlso adjusted for baseline neck
Fig. 4 Pain VAS for the three intervention groups at baseline and
study visit 5. VAS visual analogue scale
Gudavalli et al. Trials  (2015) 16:259 Page 10 of 16and 4.0 (1.8 to 6.2) for the low, medium and high force
groups, respectively. The adjusted mean NDI change
was approximately the same for the medium and high
force groups, and both had significantly more change
(2.7-3.0 points) than the low force group (Table 3).PROMIS-43 outcomes
Adjusted mean differences on the PROMIS-pain interfer-
ence and physical function were not appreciably different
between groups (Table 3). However, the mean PROMIS
fatigue change score was significantly greater for the high
traction force MCD than the low force group (5.8).Satisfaction
More high traction force participants (n = 15) were satis-
fied with the treatments they received compared to partic-
ipants in the medium (n = 9) or low traction force (n = 7)
groups. In contrast, participants in all three groups were
satisfied with the clinician who provided their care (high
force group, n = 15; medium force group, n = 14; low force
group, n = 14).Mean differencea 95 % Confidence intervala
15.6 1.6 to 29.7
9.8 −3.7 to 23.3
5.8 −8.6 to 20.3
2.7 −0.1 to 5.6
3.0 0.1 to 5.9
0.2 −2.7 to 3.2
3.9 −5.6 to 2.7
−1.5 1.0 to 0.1
5.4 −2.2 to 9.8
−0.2 −2.2 to 1.9
−1.0 −3.1 to 1.2
0.3 −1.9 to 2.5
5.8 1.1 to 10.5
3.3 −1.5 to 8.2
2.5 −2.3 to 7.3
1.3 −0.9 to 3.5
−1.4 −3.6 to 0.9
2.7 0.4 to 5.0
), Medium Medium force group (21 to 50 Newtons), PROMIS Patient-Reported
pain VAS
Fig. 5 NDI for the three intervention groups at baseline and study
visit 5. NDI Neck Disability Index
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Table 4 presents the cervical traction forces delivered to
participants. The mean values are within the prescribed
force ranges for each group at both the C5 and occiput
levels. Maximum forces were highest at the occiput level
for all three force groups. Maximum values for the light
force group reached 27 N. Minimum values for the
medium force group were as low as 8 N and as high as
70 N for the maximum values. Minimum force values
for the high force group were 31 N and maximum force
was 99 N. In some cases, clinicians delivered MCD cy-
cles outside the allocated force range.
Treatment credibility and expectancy measures
Table 5 depicts the changes in CEQ scores between treat-
ment groups over the two-week trial. Credibility factor
scores at BL1 suggest participants considered MCD, as de-
scribed in the consent document and introductory video,
to be a credible therapy for neck pain. After receiving
MCD for the first time (SV1), participants in the high
force group reported higher credibility scores from BL1,
while credibility scores fell for medium and low force
group participants. Credibility score trends continued at
the final visit, where the high force group reported theTable 4 Cervical traction forces measured in Newtons (N) over four
Force range Contact level Number of observat
Light Force (0-20 N) C5 64
Occiput 64
Medium Force (21-50 N) C5 57
Occiput 56
High Force (51-100 N) C5 60
Occiput 60
aWe recorded 23 missing values for traction forces due to 9 missed appointments (highest credibility scores, the medium force group
remained stable, and the low force group dropped six
points from BL1. Expectancy factor scores followed simi-
lar patterns. Participants in the high force group reported
greater expectancy scores after receiving MCD at SV1
compared to the other groups. However, expectancy scor-
ings dropped for all treatment groups at SV5.
Qualitative analysis of treatment group allocation
Thirty-nine (81 %) participants completed a qualitative
interview which included two questions that asked par-
ticipants to identify their treatment group assignment. No
interviews were conducted with the three participants
who withdrew from the study (two medium force, one
high force) while scheduling conflicts prevented the com-
pletion of six additional interviews (three low force, two
medium force, one high force). We completed interviews
with the majority of participants in each treatment group.
With this number of interviews, we achieved consistent
thematic coding of participants’ attributions for treatment
allocation within and across groups (largely related to the
amount of pressure or force used by clinician during treat-
ment delivery), suggesting we reached theoretical satur-
ation on this topic [78].
In the low force group, 12 of 13 (92 %) participants
correctly identified their treatment assignment as ‘low
force’. Most participants noted the light touch used by
the clinician as the reason for their treatment group at-
tribution, as indicated by this participant: “It didn’t feel
like there was much pressure being put on there.” One
low force participant incorrectly identified the treatment
allocation stating, “I believe I received the medium, but
I’m not sure. It wasn’t really tight, but it wasn’t really
soft either. It was sort of like an in-between.” In the
medium force group, 4 of 13 (31 %) participants cor-
rectly identified their treatment assignment as ‘medium
force’, with 7 participants incorrectly guessing their
group (6 as low force, 1 as high force), and 2 participants
identifying their group as ‘low-to-medium’ force. In the
high force group, 2 of 13 (15 %) participants correctly
identified their group allocation as high force, while 9
(69 %) participants incorrectly guessed their group (8 as
medium force, 1 as low force), and 2 participants assessedtreatment visits
ionsa Mean SD Minimum Maximum
13.82 5.74 0.18 23.31
17.19 4.84 0.47 26.64
38.30 12.12 8.61 59.07
42.87 10.40 7.70 69.57
65.08 17.70 30.63 89.65
74.06 16.08 37.54 98.34
18 observations) and 5 instances of technical problems in data collection
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group. The participants who correctly identified their
treatment group as high force noted the clinicians’ behav-
ior as an indicator of their assignment, such as, “He (the
chiropractor) seemed to exert himself a little bit”. In con-
trast, high force participants who incorrectly guessed their
group assignment expected more forceful sensations from
the treatment, as did this participant: “He (the chiroprac-
tor) could have pushed harder, you know?”Participant safety
No serious adverse events were documented. Fifty-seven
adverse events were reported by 29 participants (includ-
ing 1 non-randomized). However, 34 of the AEs reported
by 23 participants were graded as unrelated (n = 30) or
unlikely (n = 4) related to study interventions and were
classified as mild (n = 32) or moderate (n = 2) in severity.
Another 23 AEs were reported by 14 participants and
graded as possibly (n = 1), probably (n = 6) or definitely
(n = 15) related to study interventions. These related
AEs were all classified as mild severity (that is, transient
and minimal symptoms needing no change in activity
level or additional treatment) and were characterized as
neck or back soreness or pain (n = 14), muscle or joint
stiffness (n = 3), combined pain and stiffness (n = 2),
headache (n = 1), vertigo (n = 1), and pain paired with a
flushed sensation (n = 1). One episode of vertigo that oc-
curred within 30 hours of SV1 in a participant with pre-
vious episodes of dizziness was classified as a severe AE
that was probably related to the study interventions. Of
the 23 AEs attributed to the study, 3 AEs were reported
by 3 participants assigned to the low force group, 15
AEs were reported by 6 participants assigned to the
medium force group, and 5 AEs were reported by 5 par-
ticipants assigned to the high force group. Twenty ran-
domized participants reported no adverse events,
including nine low force, five medium force, and six high
force participants.Table 5 Credibility and expectancy questionnaire results
Baseline 1 Study visit 1 Study visit 5
Mean SD Mean SD Mean SD
Credibility factor
Low force 19.8 2.2 15.5 7.0 13.8 8.0
Medium force 23.1 3.4 19.9 5.2 19.9 7.5
High force 21.0 3.9 22.1 4.8 22.7 4.0
Expectancy factor
Low force 15.8 4.0 13.4 6.2 11.4 7.8
Medium force 19.7 4.7 17.8 5.8 15.1 8.3
High force 16.0 6.9 19.3 6.7 17.8 6.2Protocol deviation
We recorded one protocol deviation in this trial. Our
original plan was to train research clinicians to deliver
MCD at the three traction force ranges using tactile sen-
sations alone, as manual therapists deliver treatments in
clinical practice. During a monthly re-certification, in-
vestigators noted modest drift in the clinicians’ delivery
of MCD. Delivery of the low force group drifted into the
medium range, particularly for forces delivered to the
occiput, although traction forces remained under 25 N.
Medium traction forces drifted in each direction and at
both contact levels. High traction forces drifted toward
the medium range, for both vertebral levels, with most
drift measured between 30 N to 50 N; no traction forces
were noted above 100 N. To address this drift, the re-
searchers developed a visual feedback tool to augment
the auditory and graphical feedback received by clini-
cians during training (Motion Monitor software, Version
7.1, Innovative Sports Training, Inc.). The instrument
allowed clinicians to view a computer monitor displaying
visual force-feedback information in real time while per-
forming MCD. The monitor displayed a cursor which
represented traction force. The visual feedback tool was
implemented in the RCT on 27 June 2013. Clinicians
provided a total of 231 MCD treatments without visual
feedback and 218 treatments with visual feedback. We
reported the impact of this protocol change on the profi-
ciency of clinician traction force delivery elsewhere [45].
Discussion
This paper presents the results of a pilot randomized
clinical trial of MCD for patients with chronic neck pain
designed to evaluate an attention-touch control for fu-
ture clinical trials. MCD is a traction-based treatment
for cervical and thoracic spine pain and dysfunction that
is commonly delivered by DCs in the USA [79]. Poten-
tial advantages of MCD over other types of traction in-
clude its delivery in the prone position, which may
enhance the localization of manual forces applied more
specifically to a region of the spine compared with other
treatments that apply traction via straps around the
mandible and occipital region of the head. To our know-
ledge, no other studies have investigated MCD using a
force-based approach or assessed the traction forces de-
livered during MCD using biomechanical measures. In
addition, the technological advancement represented by
real-time force feedback enhances the feasibility of con-
sistent treatment delivery force [46].
One advantage of this study was its mixed methods
approach to the development of a minimal intervention
control for RCTs of traction-based therapies. Manual
therapy research has been hampered by the lack of vi-
able control procedures [32, 80–82]. As manual therap-
ies require physical contact between the clinician and
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minimal intervention that is not immediately obvious to
participants or that has no specific effect on the clinical
outcomes under investigation [81]. Vernon and col-
leagues developed a sham cervical procedure that 50 %
of participants suspected was real SM, and that had no
clinically important changes in cervical range of motion,
pain or tenderness [83]. However, this sham procedure
is a high-velocity spinal manipulation maneuver, quite
unlike the gradual spinal mobilization of MCD, making
it ill-suited as a control intervention for studies of trac-
tion procedures.
We developed a traction force-based minimal inter-
vention that demonstrated some characteristics of a suc-
cessful attention-touch control group, such as the lack
of clinically important changes in the primary outcomes.
Participants who received the low force treatment did
identify this procedure as the minimal intervention and
stated their assessment was due to the lightness of the
clinician’s touch. Further, many medium force partici-
pants incorrectly guessed that they had received the low
force intervention. As our team measured the amount of
traction force participants received at each treatment
visit, it was possible to identify the mean traction forces
delivered to each group. Based on these combined quali-
tative and traction force data, we will modify the force
ranges for the minimal intervention and MCD groups in
future studies. An increase in the minimal intervention
traction force range from 0 to 20 N to 15 to 30 N should
enhance treatment credibility (that is, the lightness of
the clinician’s touch) while still minimizing the treat-
ment effect. In this pilot, the traction force range for the
high force group was 51 to 100 N. To maximize the dis-
tinction between a minimal intervention and the MCD
group in future trials, we will set the MCD traction force
range at 60 to 100 N, which is consistent with the peak
forces measured in the high force group, as well as par-
ticipants’ qualitative assessments of treatment delivery in
this group. Future trials should conduct similar qualita-
tive assessment to ascertain whether these modifications
adequately enhance the credibility of the minimal inter-
vention control.
The changes in patient-reported outcomes during this
pilot were promising. Group differences were demon-
strated on the neck pain VAS and NDI for the medium
force and high force groups compared to the low force
group. Unexpected, but intriguing changes were the
group differences noted in fatigue and sleep disturbance
outcomes. However, differences in the primary and sec-
ondary outcomes between the medium and high force
groups were negligible. In part, this finding may be due
the overlap in traction forces between groups noted
midway through the trial which was resolved by the use
of visual force feedback technology [46]. Future studiesof MCD might opt to compare treatment groups with
more distinct differences such as Snodgrass et al. reported
in a pilot study utilizing a force-based posterior-to-
anterior mobilization procedure [84]. In that study, signifi-
cant reductions in pain and spinal stiffness were reported
in participants receiving the high force posterior-to-
anterior mobilization (90 N) compared to low force
(30 N) or placebo [84]. As the greatest improvements in
neck pain severity and neck-related disability in our study
were reported by the high traction force group, a fully
powered future RCT might compare high force traction
to a minimal intervention, attention-touch control.
Of note, the improvements in PROs reported in this
study were achieved in a pilot RCT that was only two
weeks in duration. Future RCTs that evaluate MCD might
extend the course of care to four or six weeks, as is deliv-
ered in clinical practice [34] and in recent clinical trials of
traction-based therapies which demonstrated both short-
term and longer term improvements in neck pain intensity
and disability following four weeks of treatment [24, 85].
Additional aims of this pilot study were to assess the
feasibility of the participant recruitment plan and to
evaluate the safety of force-based delivery of MCD.
Community interest in this trial was good as evidenced
by the consistent participant recruitment, enrollment
and trial completion. We enrolled a middle-aged sample
with the majority of participants being women, which is
consistent with the patient population that reports mus-
culoskeletal neck pain [7, 8]. Data collection took nine
months, nearly three months sooner than anticipated
during study development. Few participants missed any
visits, only three participants withdrew from the trial,
and none were from the low force group. These results
support the feasibility of our participant recruitment
plan for a fully-powered randomized controlled trial.
Additional recruitment methods that might enhance en-
rollment during a larger trial are outreach to community
groups, press releases and social media announcements,
particularly those targeting populations in which neck
pain is a prominent concern such as middle aged
women, as well as the possible addition of financial in-
centives [49, 86]. We randomized participants who re-
ported symptoms consistent with QTF classifications 2
(neck pain with radiation to proximal extremities) and 3
(neck pain with radiation to distal extremities). In future
trials of MCD, researchers may consider partnering with
healthcare providers who treat persons with chronic
neck pain to identify potential participants with these
clinical characteristics.
During our pilot, we limited our inclusion criteria to
participants who rated their neck pain at baseline as be-
tween 3 and 7 on the NRS as a safety precaution. Thus,
a number of potential participants (n = 32) were ex-
cluded for pain severity levels of 8, 9 or 10 on the NRS.
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lated to study interventions reported in the trial, which
were equally distributed between groups, of mild or
moderate severity, and followed established patterns of
adverse events from spinal mobilization reported in the
literature [69, 73, 74, 87], opening eligibility criteria to
include persons with greater neck pain severity levels
seems acceptable and would likely increase participant
eligibility for a larger trial.
This pilot RCT had several limitations. As in manual
therapy trials generally [88], the clinicians who delivered
the intervention were not blinded to treatment group
nor were the biomechanics research assistants blinded
to force measurements. Both types of personnel received
extensive training and followed an explicit script to pre-
vent the inadvertent unblinding of study participants to
their treatment group. In addition, study participants were
excluded if they reported high levels of neck pain, cervical
fusion, and several other co-morbid conditions which are
common among persons with chronic neck pain [2]. No
additional measures were employed to control for the
angle of distraction, which theoretically varies between
participants who inherently exhibit varied morphology.
Characteristics affecting the angle of distraction could in-
clude thoracic cage diameter, breast tissue, abdominal tis-
sue, and cervico-thoracic curvature.
Our study tested a single component of MCD – trac-
tion in a neutral head position – which is thought to be
the most important component contributing therapeutic
benefit [34]. However, practitioners who use MCD often
incorporate multiple manually delivered therapies fo-
cused on the cervical and thoracic spine into their treat-
ment regimens. In addition, the manual contact points
treated in clinical practice may differ from those in this
study (C5, occiput). Also, the number of treatments pro-
vided (n = 5) is potentially dissimilar to the use of MCD
in practice settings, in that the clinician determines the
frequency and duration of treatment based on the type
and severity of the condition, the patient’s response to
treatment, and the patient’s care phase (acute, subacute,
chronic, rehabilitation) [34]. Our decision to standardize
these delivery components of the MCD intervention in-
creased the rigor of this pilot RCT, but may have limited
the participants’ clinical response to the intervention. If
the efficacy of traction with a neutral head position is
established, trials to assess the full complement of the
MCD intervention may be warranted.
Another limitation is the cost of the equipment used to
measure traction forces. Gudavalli et al. reported on the
proficiency of trained DCs demonstrating 75 % proficiency
with no feedback and 97 % with visual feedback [46]. The
technology used in this study was developed for research
purposes rather than clinical application. This equipment
may be cost prohibitive for many clinicians to purchasefor their practice settings. The development of a low cost
technology to offer force feedback in practice settings is
feasible and would advance the training of manual
therapists.
Conclusions
This paper reports the primary findings of a pilot ran-
domized clinical trial of MCD for adult patients with
chronic neck pain designed to develop a minimal inter-
vention to serve as an attention-touch control for future
studies. Participants who received the medium (21 N to
50 N) to high (51 N to 100 N) traction force MCD re-
ported clinically important improvements in neck pain
intensity and neck-related disability compared to partici-
pants who received low (≤20 N) traction force MCD.
These improvements in clinical outcomes were noted
after only four sessions of MCD delivered over a two-
week period. Adverse events were of mild or moderate
severity and self-resolved, demonstrating the safety of
the intervention. These data support undertaking a fully
powered, randomized controlled trial of MCD using the
minimal intervention as an attention-touch control.
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